Alexopoulos Alexopoulos A A Buse Buse JB JB Initial injectable therapy in type 2 diabetes: key considerations when chosing between glucagon-like pepetide 1 receptor agonists and insulin Initial injectable therapy in type 2 diabetes: key considerations when chosing between glucagon-like pepetide 1 receptor agonists and insulin Metabolism Metabolism 2019 2019 98 98 104 104 111 111 10.1016/j.metabol.2019.06.012 10.1016/j.metabol.2019.06.012 supplied-pmid 31255662? Here, INS is linked to type 2 diabetes mellitus.